Get startedLog in
    Picture of Kiora Pharmaceuticals logo

    KPRX — Kiora Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: EyeGate Announces $10.75 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Picture of Kiora Pharmaceuticals logoKiora Pharmaceuticals
    10/08/2021 11:59
    Aug 10 (Reuters) - EyeGate Pharmaceuticals Inc  EYEG.O :
    * EYEGATE ANNOUNCES $10.75 MILLION REGISTERED DIRECT
OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
    * EYEGATE PHARMACEUTICALS - ENTERED INTO AGREEMENTS WITH
SEVERAL
INVESTORS FOR PURCHASE & SALE OF 4.7 MILLION SHARES OF COMMON
STOCK AT $2.3025/SHARE

Source text for Eikon:  ID:nGNX112jrC 
Further company coverage:  EYEG.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kiora Pharmaceuticals

    See all news